Early Hepatocellular Carcinoma and Dysplastic Nodules

 

 Buy Article Permissions and Reprints

ABSTRACT

It has been established that small, equivocal nodular lesions such as dysplastic nodules (DNs) and small well-differentiated hepatocellular carcinomas (early HCCs) are frequently observed in noncancerous liver tissues resected along with HCCs and in explant cirrhotic livers. DNs are classified into low-grade DNs or high-grade DNs on the basis of cytological and architectural atypia; high-grade DNs show varying degrees of cytological or architectural atypia, or both. Early HCCs are indistinctly nodular and highly differentiated and are frequently difficult to differentiate from high-grade DNs. Although the pathological diagnosis of high-grade DNs and early HCCs is controversial, the presence of tumor cell invasion into the intratumoral portal tracts (stromal invasion) is a helpful clue for differentiating early HCC from high-grade DNs. It is highly suggested that many HCCs occurring in cirrhotic liver arise in DNs and develop to classical HCC in a multistep fashion.

REFERENCES

• 1 Furuya K, Nakamura M, Yamamoto Y, Togei K, Otsuka H. Macroregenerative nodule of the liver. A clinicopathological study of 345 autopsy cases of chronic liver disease.  Cancer. 1988;  61 99-105
  PubMedGoogle Scholar
• 2 Wada K, Kondo Y, Kondo F. Large regenerative nodules and dysplastic nodules in cirrhotic livers: a histopathologic study.  Hepatology. 1988;  8 1684-1688
  PubMedGoogle Scholar
• 3 Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma.  Hum Pathol. 1991;  22 172-178
  CrossrefPubMedGoogle Scholar
• 4 Mion F, Grozel L, Boillot O, Paliard P, Berger F. Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas.  Gastroenterology. 1996;  111 1587-1592
  CrossrefPubMedGoogle Scholar
• 5 Eguchi A, Nakashima O, Okudaira S et al.. Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma.  Hepatology. 1992;  15 843-848
  PubMedGoogle Scholar
• 6 Terada T, Terasaki S, Nakanuma Y. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy.  Cancer. 1993;  72 1551-1556
  CrossrefPubMedGoogle Scholar
• 7 Ferrell L, Wright T, Lake J et al.. Incidence and diagnostic features of macroregenerative nodules vs small hepatocellular carcinoma in cirrhotic livers.  Hepatology. 1992;  16 1372-1381
  CrossrefPubMedGoogle Scholar
• 8 Nakashima O, Sugihara S, Kage M, Kojiro M. Pathomorphologic characteristics of small hepatocellular carcinoma: a special reference to small hepatocellular carcinoma with indistinct margins.  Hepatology. 1995;  22 101-105
  CrossrefPubMedGoogle Scholar
• 9 Kojiro M, Nakashima O. Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumor.  Semin Liver Dis. 1999;  19 287-296
  PubMedGoogle Scholar
• 10 Kondo F, Ebara M, Sugiura N et al.. Histological features and clinical course of large regenerative nodules: evaluation of their precancerous potentiality.  Hepatology. 1990;  12 592-598
  PubMedGoogle Scholar
• 11 Kaji K, Terada T, Nakanuma Y. Frequent occurrence of hepatocellular carcinoma in cirrhotic livers after surgical resection of atypical adenomatous hyperplasia (borderline hepatocellular lesion): a follow-up study.  Am J Gastroenterol. 1994;  89 903-908
  PubMedGoogle Scholar
• 12 Sakamoto M, Hirohashi S. Natural history and prognosis of adenomatous hyperplasia and early hepatocellular carcinoma: multi-institutional analysis of 53 nodules followed up for more than 6 months and 141 patients with single early hepatocellular carcinoma treated by surgical resection or percutaneous ethanol injection.  Jpn J Clin Oncol. 1998;  28 604-608
  CrossrefPubMedGoogle Scholar
• 13 Takayama T, Makuuchi M, Hirohashi S et al.. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma.  Lancet. 1990;  336 1150-1153
  CrossrefPubMedGoogle Scholar
• 14 International Working Party . Terminology of nodular lesions of the liver: recommendations of the World Congress of Gastroenterology Working Group.  Hepatology. 1995;  22 983-993
  CrossrefPubMedGoogle Scholar
• 15 Theise N D, Schwartz M, Miller C et al.. Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver explants with cirrhosis.  Hepatology. 1992;  16 949-955
  CrossrefPubMedGoogle Scholar
• 16 Hytiroglou P, Theise N D, Schwartz M et al.. Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature.  Hepatology. 1995;  21 703-708
  CrossrefPubMedGoogle Scholar
• 17 Le Bail B, Belleannee G, Bernard P-H et al.. Adenomatous hyperplasia in cirrhotic livers: histological evaluation, cellular density, and proliferative activity of 35 lesions in the cirrhotic explants of 10 adult French patients.  Hum Pathol. 1995;  26 897-906
  CrossrefPubMedGoogle Scholar
• 18 Kojiro M. Focus on dysplastic nodules and early hepatocellular carcinoma: an eastern point of view.  Liver Transpl. 2004;  10 S3-S8
  CrossrefPubMedGoogle Scholar
• 19 Roncalli M. Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A western experience.  Liver Transpl. 2004;  10 S9-S19
  CrossrefPubMedGoogle Scholar
• 20 Watanabe S, Okita K, Harada T et al.. Morphologic studies of the liver cell dysplasia.  Cancer. 1983;  51 2197-2205
  PubMedGoogle Scholar
• 21 Anthony P P, Vogel C L, Barker L F. Liver cell dysplasia: a premalignant condition.  J Clin Pathol. 1973;  26 217-223
  CrossrefPubMedGoogle Scholar
• 22 Le Bail B, Bernard P-H, Carles J, Balabaud C, Bioulac-Sage P. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants.  J Hepatol. 1997;  27 835-842
  CrossrefPubMedGoogle Scholar
• 23 Zhao M, Zhang N, Du Z, Laissue J, Zimmerman A. Three types of liver cell dysplasia (LCD) in small cirrhotic nodules are distinguishable by karyometry and PCNA labelling, and their features resemble distinct grades of hepatocellular carcinoma.  Histol Histopathol. 1994;  9 73-83
  PubMedGoogle Scholar
• 24 Makino Y, Shiraki K, Sugimoto K et al.. Histological features of cirrhosis with hepatitis C virus for prediction of hepatocellular carcinoma development; a prospective study.  Anticancer Res. 2000;  20 3709-3715
  PubMedGoogle Scholar
• 25 Adachi E, Hashimoto H, Tsuneyoshi M. Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia.  Cancer. 1993;  72 2902-2909
  PubMedGoogle Scholar
• 26 Zhao M, Zimmermann A. Liver cell dysplasia: reactivities for c-met protein, Rb protein, E-cadherin and transforming growth factor-beta 1 in comparison with hepatocellular carcinoma.  Histol Histopathol. 1998;  13 657-670
  PubMedGoogle Scholar
• 27 Marchio A, Terris B, Meddeb M et al.. Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation.  Mol Pathol. 2001;  54 270-274
  PubMedGoogle Scholar
• 28 Libbrecht L, Desmet V, Van Damme B, Roskams T. The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells.  J Hepatol. 2000;  33 76-84
  CrossrefPubMedGoogle Scholar
• 29 Libbrecht L, De Vos R, Cassiman D, Desmet V, Aerts R, Roskams T. Hepatic progenitor cells in hepatocellular adenomas.  Am J Surg Pathol. 2001;  25 1388-1396
  CrossrefPubMedGoogle Scholar
• 30 Fausto N, Lemire J M, Shiojiri N. Oval cells in liver carcinogenesis: cell lineages in hepatic development and the identification of facultative stem cells in normal liver. In: Sirica AE The Role of Cell Types in Hepatocarcinogenesis Boca Raton, FL; CRC Press 1992: 89-109
  Google Scholar
• 31 Ogawa K, Minase T, Onhoe T. Demonstration of glucose 6-phosphatase activity in the oval cells of rat liver and the significance of the oval cells in azo dye carcinogenesis.  Cancer Res. 1974;  34 3379-3386
  PubMedGoogle Scholar
• 32 Dumble M L, Croager E J, Yeoh G C, Quail E A. Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma.  Carcinogenesis. 2002;  23 435-445
  CrossrefPubMedGoogle Scholar
• 33 Roskams T. Progenitor cell involvement in cirrhotic human liver diseases: from controversy to consensus.  J Hepatol. 2003;  39 431-434
  CrossrefPubMedGoogle Scholar
• 34 Roskams T, Libbrecht L, Desmet V. Progenitor cells in diseased human liver.  Semin Liver Dis. 2003;  23 385-396
  Article in Thieme ConnectPubMedGoogle Scholar
• 35 Libbrecht L, Roskams T. Hepatic progenitor cells in human liver diseases.  Semin Cell Dev Biol. 2002;  13 389-396
  CrossrefPubMedGoogle Scholar
• 36 Roncalli M, Borzio M, Brando B, Colloredo G, Servida E. Abnormal DNA content in liver-cell dysplasia: a flow cytometric study.  Int J Cancer. 1989;  44 204-207
  PubMedGoogle Scholar
• 37 Thoenes W, Storkel S, Rumpelt H. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics.  Pathol Res Pract. 1986;  181 125-143
  PubMedGoogle Scholar
• 38 Thomas R M, Berman J J, Yetter R A, Moore G W, Hutchins G M. Liver cell dysplasia: a DNA aneuploid lesion with distinct morphologic features.  Hum Pathol. 1992;  23 496-503
  CrossrefPubMedGoogle Scholar
• 39 Lee R G, Tsamandas A C, Demetris A J. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis.  Hepatology. 1997;  26 1415-1422
  PubMedGoogle Scholar
• 40 Santoni Rugiu E, Nagy P, Jensen M R, Factor V M, Thorgeirsson S S. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.  Am J Pathol. 1996;  149 407-428
  PubMedGoogle Scholar
• 41 Libbrecht L, Desmet V, Van Damme B, Roskams T. The expression of p16 in liver cell dysplasia in human cirrhotic liver.  Eur J Cancer Prev. 2000;  9 444
  PubMedGoogle Scholar
• 42 Ferrell L. Liver pathology: cirrhosis, hepatitis, and primary liver tumors. Update and diagnostic problems.  Mod Pathol. 2000;  13 679-704
  CrossrefPubMedGoogle Scholar
• 43 Borzio M, Bruno S, Roncalli M et al.. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study.  Gastroenterology. 1995;  108 812-817
  CrossrefPubMedGoogle Scholar
• 44 Libbrecht L, Craninx M, Nevens F, Desmet V, Roskams T. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis.  Histopathology. 2001;  39 66-73
  CrossrefPubMedGoogle Scholar
• 45 Gaasbeek J W, Westenend P J, Charles R, Lamers W, Moorman A FM. Gene expression in derivatives of embryonic foregut during prenatal development of the rat.  J Histochem Cytochem. 1988;  36 1223-1230
  PubMedGoogle Scholar
• 46 Ganne-Carrie N, Chastang C, Chapel F et al.. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.  Hepatology. 1996;  23 1112-1118
  PubMedGoogle Scholar
• 47 Deugnier Y M, Charalambous P, Le Quilleuc D et al.. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients.  Hepatology. 1993;  18 1363-1369
  CrossrefPubMedGoogle Scholar
• 48 Libbrecht L, Desmet V, Roskams T. Preneoplastic lesions in human hepatocarcinogenesis.  Liver Int. 2005;  25 16-27
  CrossrefPubMedGoogle Scholar
• 49 Party I W. Terminology of chronic hepatitis, hepatic allograft rejection, and nodular lesions of the liver: summary of recommendations developed by an international working party, supported by the World Congresses of Gastroenterology, Los Angeles, 1994.  Am J Gastroenterol. 1994;  89 S177-S181
  PubMedGoogle Scholar
• 50 Arakawa M, Kage M, Sugihara S, Nakashima T, Suenaga M, Okuda K. Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver. Observations in five cases.  Gastroenterology. 1986;  91 198-208
  PubMedGoogle Scholar
• 51 Terada T, Nakanuma Y. Survey of iron-accumulative macroregenerative nodules in cirrhotic livers.  Hepatology. 1989;  10 851-854
  CrossrefPubMedGoogle Scholar
• 52 Hytiroglou P. Morphological changes of early human hepatocarcinogenesis.  Semin Liver Dis. 2004;  24 65-75
  Article in Thieme ConnectPubMedGoogle Scholar
• 53 Kojiro M. Premalignant lesions of hepatocellular carcinoma: pathologic viewpoint.  J Hepatobiliary Pancreat Surg. 2000;  7 535-541
  CrossrefPubMedGoogle Scholar
• 54 Terada T, Nakanuma Y. Arterial elements and perisinusoidal cells in borderline hepatocellular nodules and small hepatocellular carcinomas.  Histopathology. 1995;  27 333-339
  CrossrefPubMedGoogle Scholar
• 55 Park Y N, Yang C P, Fernandez G J, Cubukcu O, Thung S N, Theise N D. Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver.  Am J Surg Pathol. 1998;  22 656-662
  CrossrefPubMedGoogle Scholar
• 56 Roncalli M, Roz E, Coggi G et al.. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification.  Hepatology. 1999;  30 1174-1178
  CrossrefPubMedGoogle Scholar
• 57 Maggioni M, Coggi G, Cassani B et al.. Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies.  Hepatology. 2000;  32 942-946
  CrossrefPubMedGoogle Scholar
• 58 Sun M, Eshleman J R, Ferrell L D et al.. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.  Hepatology. 2001;  33 1415-1424
  CrossrefPubMedGoogle Scholar
• 59 Tornillo L, Carafa V, Sauter G et al.. Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma.  Lab Invest. 2002;  82 547-553
  CrossrefPubMedGoogle Scholar
• 60 Borzio M, Fargion S, Borzio F et al.. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development.  J Hepatol. 2003;  39 208-214
  CrossrefPubMedGoogle Scholar
• 61 Paradis V, Bieche I, Dargere D et al.. Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach: determination of a molecular diagnostic index.  Am J Pathol. 2003;  163 733-741
  CrossrefPubMedGoogle Scholar
• 62 Hytiroglou P, Kotoula V, Thung S N, Tsokos M, Fiel M I, Papadimitriou C S. Telomerase activity in precancerous hepatic nodules.  Cancer. 1998;  82 1831-1838
  CrossrefPubMedGoogle Scholar
• 63 Oh B K, Jo Chae K, Park C et al.. Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis.  J Hepatol. 2003;  39 786-792
  CrossrefPubMedGoogle Scholar
• 64 Liver Cancer Study Group of Japan .Classification of Primary Liver Cancer. 2nd ed. Tokyo; Kanehara & Co 2004
  Google Scholar
• 65 Wachsberg R H, Klein K M, Von Hagen S. Non-Asian hepatocellular carcinoma: correlation between histologic features and echogenicity.  J Ultrasound Med. 2000;  19 687-688
  PubMedGoogle Scholar
• 66 Kutami R, Nakashima Y, Nakashima O et al.. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans.  J Hepatol. 2000;  33 282-289
  CrossrefPubMedGoogle Scholar
• 67 Kondo F, Kondo Y, Nagato Y et al.. Intestinal tumour cell invasion in small hepatocellular carcinoma. Evaluation in microscopic and low magnification views.  J Gastroenterol Hepatol. 1994;  9 604-612
  PubMedGoogle Scholar
• 68 Tomizawa M, Kondo F, Kondo Y. Growth patterns and interstitial invasion of small hepatocellular carcinoma.  Pathol Int. 1995;  45 352-358
  PubMedGoogle Scholar
• 69 Nakano M, Saito A, Yamamoto M, Doi M, Takasaki K. Stromal invasion and blood vessel wall invasion in well differentiated hepatocellular carcinoma.  Liver. 1997;  17 41-46
  PubMedGoogle Scholar
• 70 Dhillon A, Colombari R, Savage K et al.. An immunohistochemical study of the blood vessels within primary hepatocellular tumors.  Liver. 1992;  12 311-318
  PubMedGoogle Scholar
• 71 Nakashima Y, Nakashima O, Hsia C C et al.. Vascularization of small hepatocellular carcinomas: correlation with differentiation.  Liver. 1999;  19 12-18
  PubMedGoogle Scholar
• 72 Kimura H, Nakajima T, Kagawa K et al.. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry.  Liver. 1998;  18 14-19
  PubMedGoogle Scholar
• 73 Maeda T, Adachi E, Kajiyama K et al.. CD34 expression in endothelial cells of small hepatocellular carcinoma: its correlation with tumor progression and angiographic findings.  J Gastroenterol Hepatol. 1995;  10 650-654
  CrossrefPubMedGoogle Scholar
• 74 Enzan H, Himeno H, Iwamura S et al.. Alpha-smooth muscle actin-positive perisinusoidal stromal cells in human hepatocellular carcinoma.  Hepatology. 1994;  19 895-903
  CrossrefPubMedGoogle Scholar
• 75 Kenmochi K, Sugihara S, Kojiro M. Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grade in single HCC.  Liver. 1987;  7 18-26
  PubMedGoogle Scholar
• 76 Sugihara S, Nakashima O, Kojiro M et al.. The morphologic transition in hepatocellular carcinoma-a comparison of the individual histological features disclosed by ultrasound-guided fine-needle biopsy with at autopsy.  Cancer. 1992;  70 1488-1492
  PubMedGoogle Scholar
• 77 Kojiro M. Pathology of early HCC: progression from early to advanced.  Hepatogastroenterology. 1998;  45 1203-1205
  PubMedGoogle Scholar
• 78 Matsuno Y, Hirohashi S, Furuya S et al.. Heterogeneity of proliferative activity in nodule-in-nodule lesions of small hepatocellular carcinoma.  Jpn J Cancer Res. 1990;  81 1137-1140
  PubMedGoogle Scholar
• 79 Yano H, Iemura A, Fukuda K et al.. Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells.  Hepatology. 1993;  18 320-327
  CrossrefPubMedGoogle Scholar
• 80 Morimitsu Y, Hsia C, Kojiro M et al.. Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma. Relative expression of transforming growth factor-alpha and its receptor in the different areas of tumor.  Hum Pathol. 1995;  26 1126-1132
  CrossrefPubMedGoogle Scholar
• 81 Koga H, Sakisaka S, Ohnishi M et al.. Expression of cyclooxigenese-2 in human hepatocellular carcinoma: relevance to dedifferentiation.  Hepatology. 1999;  29 688-696
  CrossrefPubMedGoogle Scholar

Masamichi KojiroM.D. 

Department of Pathology, Kurume University School of Medicine

67 Asahi-machi, Kurume-shi 830-0011, Japan

Email: kojiro@med.kurume-u.ac.jp